Selectively depolymerized galactomannan polysaccharide
US7893252B2 · kind B2 · utility
21Cited by
61References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 25, 2008 |
| Grant date | Feb 22, 2011 |
| Priority date | — |
| Expiry date | Feb 25, 2028 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Disclosed herein are compositions and methods for treating diseases such as cancer. The compositions comprise one or more polysaccharides in an admixture with one or more therapeutic agents. This admixture can be administered to a subject in need thereof using any known method of administration. The therapeutic agent, if administered alone, can cause undesirable side-effects in the subject. The polysaccharide component minimizes or eliminates these side effects. The compositions described herein effectuate an enhanced therapeutic effect along with reduced toxicity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.